| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |